TS

Tulshidas Shankar Rao Kalekar

Active Director Director DIN 08527155
DIN 08527155 First appointment Aug 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Tulshidas Shankar Rao Kalekar

Data last updated:

Tulshidas Shankar Rao Kalekar is a Director at Medonics Medico Private Limited (since 2019). The company operates in Chemicals.

DIN 08527155
Primary Designation Director
Industry Chemicals
First Appointment 02 Aug 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medonics Medico Private Limited U24290PN2019PTC185828
Director02 Aug 20192019Active

Board colleagues of Tulshidas Shankar Rao Kalekar

NameDINCompanyDesignation
Nilesh08527156Medonics Medico Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medonics Medico Private Limited
Premium access

Shareholding and investment profile for Tulshidas Shankar Rao Kalekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tulshidas Shankar Rao Kalekar

Tulshidas Shankar Rao Kalekar currently holds 1 directorship: Medonics Medico Private Limited (Director, since 02 Aug 2019).

Tulshidas Shankar Rao Kalekar was first appointed on 02 Aug 2019 as Director at Medonics Medico Private Limited.

The current boards of Tulshidas Shankar Rao Kalekar's companies include Nilesh (Medonics Medico Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available